Recludix Pharma Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
53
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$21.5M
- Investors
-
6
Recludix Pharma General Information
Description
Operator of a drug discovery company intended to treat cancer and autoimmune diseases. The company's platform combines custom DNA-encoded libraries, massively parallel structure-activity relationship profiling, and proprietary selectivity screening tools, enabling pharmaceutical researchers and drug developers to address previously inaccessible protein targets, optimize candidate molecules through iterative design cycles, and advance novel therapies for inflammatory and immune-mediated conditions with improved precision and therapeutic potential.
Contact Information
Website
www.recludixpharma.comCorporate Office
- 3010 Science Park Road
- Suite 200
- San Diego, CA 92121
- United States
Corporate Office
- 3010 Science Park Road
- Suite 200
- San Diego, CA 92121
- United States
Recludix Pharma Timeline
Recludix Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 12-Jan-2026 | $21.5M | Completed | Clinical Trials - General | ||
| 3. Later Stage VC (Series A) | Completed | Clinical Trials - General | ||||
| 2. Accelerator/Incubator | 11-Mar-2025 | $60M | Completed | Clinical Trials - General | ||
| 1. Early Stage VC (Series A) | 15-Nov-2021 | $60M | $60M | Completed | Clinical Trials - General |
Recludix Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Recludix Pharma Patents
Recludix Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026107062-A1 | Stat6 degraders and uses thereof | Pending | 13-Nov-2024 | ||
| US-12709628-B2 | Stat6 modulators and uses thereof | Active | 12-Jul-2024 | ||
| US-20260015373-A1 | Stat6 modulators and uses thereof | Active | 12-Jul-2024 | ||
| WO-2026015868-A1 | Stat6 modulators and uses thereof | Pending | 12-Jul-2024 | ||
| WO-2025240354-A1 | Methods for screening compounds | Pending | 13-May-2024 | C07K14/4705 |
Recludix Pharma Signals
Recludix Pharma Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Lilly USA | Corporation | Minority | ||
| CONNECT (San Diego) | Accelerator/Incubator | |||
| Access Biotechnology | Corporate Venture Capital | Minority | ||
| New Enterprise Associates | Venture Capital | Minority |
Recludix Pharma FAQs
-
When was Recludix Pharma founded?
Recludix Pharma was founded in 2019.
-
Where is Recludix Pharma headquartered?
Recludix Pharma is headquartered in San Diego, CA.
-
What is the size of Recludix Pharma?
Recludix Pharma has 53 total employees.
-
What industry is Recludix Pharma in?
Recludix Pharma’s primary industry is Drug Discovery.
-
Is Recludix Pharma a private or public company?
Recludix Pharma is a Private company.
-
What is the current valuation of Recludix Pharma?
The current valuation of Recludix Pharma is .
-
What is Recludix Pharma’s current revenue?
The current revenue for Recludix Pharma is .
-
How much funding has Recludix Pharma raised over time?
Recludix Pharma has raised $123M.
-
Who are Recludix Pharma’s investors?
Alexandria Venture Investments, Lilly USA, CONNECT (San Diego), Access Biotechnology, and New Enterprise Associates are 5 of 6 investors who have invested in Recludix Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process